Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label, multiple dose, phase I study in healthy volunteers to determine the pharmacokinetic, safety and tolerability profiles of oxymorphone delivered from a transdermal oxymorphone patch to promote pain relief

Next Previous
X
Search
Trial Profile

An open label, multiple dose, phase I study in healthy volunteers to determine the pharmacokinetic, safety and tolerability profiles of oxymorphone delivered from a transdermal oxymorphone patch to promote pain relief

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxymorphone (Primary)
  • Indications Pain
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms POHO32-13
  • Sponsors Phosphagenics

    • Most Recent Events

    • 11 Aug 2014 According to a Phosphagenics media release, the data generated from this and one other study (see CT profile 700247290) will be used to help design the upcoming Phase 2 study (see CT profile 700230884) and support the IND application with the FDA.
    • 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
    • 23 Oct 2013 Status changed from recruiting to completed, as reported by a Phosphagenics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top